Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 12, Issue 5, Pages 555-565
Publisher
Informa UK Limited
Online
2013-05-10
DOI
10.1586/erv.13.36
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Economics of vaccines revisited
- (2013) Maarten J. Postma et al. Human Vaccines & Immunotherapeutics
- Population- versus Cohort-Based Modelling Approaches
- (2012) Olivier Ethgen et al. PHARMACOECONOMICS
- The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt
- (2012) Mark P. Connolly et al. PHARMACOECONOMICS
- Re: Cost-effectiveness of pertussis booster vaccination in the Netherlands
- (2012) James F. O’Mahony VACCINE
- Cost-effectiveness of pertussis booster vaccination in the Netherlands
- (2012) Mark H. Rozenbaum et al. VACCINE
- Response on “RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands”
- (2012) Mark H. Rozenbaum et al. VACCINE
- On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches
- (2012) Tjalke A. Westra et al. VALUE IN HEALTH
- Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5
- (2012) Richard Pitman et al. VALUE IN HEALTH
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Accumulating evidence for the case of differential discounting
- (2012) Maarten J Postma et al. Expert Review of Clinical Pharmacology
- Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
- (2011) Mark H Rozenbaum et al. BMC PUBLIC HEALTH
- Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence
- (2011) Johannes A. Bogaards et al. EPIDEMIOLOGY
- Until Which Age Should Women Be Vaccinated Against HPV Infection? Recommendation Based on Cost-effectiveness Analyses
- (2011) Tjalke A. Westra et al. JOURNAL OF INFECTIOUS DISEASES
- Health Economic and Infectious Disease Modelling
- (2011) Andrea Anonychuk et al. PHARMACOECONOMICS
- Modelling the Epidemiology of Infectious Diseases for Decision Analysis
- (2011) Mark Jit et al. PHARMACOECONOMICS
- Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis
- (2011) Tjalke A. Westra et al. VALUE IN HEALTH
- Practical Implications of Differential Discounting in Cost-Effectiveness Analyses with Varying Numbers of Cohorts
- (2011) James F. O'Mahony et al. VALUE IN HEALTH
- Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum Malaria
- (2011) Nicolas Maire et al. VALUE IN HEALTH
- Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
- (2010) Alessia Melegaro et al. BMC INFECTIOUS DISEASES
- Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
- (2010) Sean T. Duggan DRUGS
- Discounting and decision making in the economic evaluation of health-care technologies
- (2010) Karl Claxton et al. HEALTH ECONOMICS
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Response: Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
- (2010) M. H. Rozenbaum et al. JNCI-Journal of the National Cancer Institute
- Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
- (2010) Robin de Vries et al. PLoS One
- Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11
- (2010) M. Brisson et al. SEXUALLY TRANSMITTED INFECTIONS
- Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis
- (2010) Nicolas Van de Velde et al. VACCINE
- Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine☆
- (2010) Till Bärnighausen et al. VACCINE
- Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis
- (2010) Cornelis Boersma et al. VALUE IN HEALTH
- Varicella vaccination in Europe – taking the practical approach
- (2009) Paolo Bonanni et al. BMC Medicine
- Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
- (2009) I. M. C. M. de Kok et al. JNCI-Journal of the National Cancer Institute
- Cost-Effectiveness Analyses of Vaccination Programmes
- (2009) Sun-Young Kim et al. PHARMACOECONOMICS
- Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: Adaptation of an existing cohort model to the situation in the Netherlands
- (2009) R.M. Rogoza et al. VACCINE
- The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe
- (2009) Mark Jit et al. VACCINE
- Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands: Recent publication reinforces favorable cost-effectiveness despite misleading conclusion
- (2009) Maarten J. Postma VACCINE
- Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
- (2009) Yoon Hong Choi et al. VACCINE
- WHO Guide for standardisation of economic evaluations of immunization programmes
- (2009) Damian G. Walker et al. VACCINE
- HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness
- (2008) Veerle M.H. Coupé et al. INTERNATIONAL JOURNAL OF CANCER
- Funding of drugs: do vaccines warrant a different approach?
- (2008) Philippe Beutels et al. LANCET INFECTIOUS DISEASES
- Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium
- (2008) Joke Bilcke et al. MEDICAL DECISION MAKING
- Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model
- (2008) Beate Sander et al. VALUE IN HEALTH
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
- (2008) Joël Mossong et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now